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Pseudomyxoma peritonei, also known as adenomucinosis or jelly-belly, is enlisted 
as very rare and recurrent clinical condition accidently diagnosed by surgeons 
during laparotomy and laparoscopy. It is characterized by excessive extracellular 
mucin accumulation in peritoneal cavity due to leakage of mucin secreting cells 
from a mucinous tumor of appendix. There is an exception where this condition 
arises from mucinous tumor of ovary. We present an interesting case where a 40 
years old woman presented with an ovarian mass and intraoperatively abdominal 
cavity was found to be filled with huge mucinous ascites and big ovarian tumor. 
Surgical debulking was done and the histopathology report demonstrated a well 
differentiated adenocarcinoma of ovary with mucin deposits in the omentum and a 
malignant variant of pseudomyxoma peritonei (Peritoneal mucinous 
carcinomatosis).  
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Introduction  
Pseudomyxoma peritonei (PMP) is a very rare clinical condition also known as 
adenomucinosis or gelatinous ascites with an estimated incidence of one to two cases 
per million per year1. It is usually encountered accidently during the surgery, and this 
pathology is seen in two of 10,000 laparotomies2. This condition usually has its origin 
from ruptured appendiceal mucinous adenoma, though there are some case reports 
where PMP is seen in presence of normal appendix or prior appendectomy3. It also 
shows association with mucinous malignancies of ovary, colon, urachus, biliary tree, 
stomach and uterus.  There occurs progressive accumulation of large amount of 
extracellular mucin in the peritoneal cavity and metastatic implants on peritoneum and 
omentum.. WERTH coined the term Pseudomyxoma peritonei and he found its 
association with an mucinous tumour of ovary in 18842. It is pathologically and 
prognostically classified in three distinct categories such as DPAM (Disseminated 
peritoneal adenomucinosis), PMCA (Peritoneal mucinous carcinomatosis) and an 
intermediate group4. A case of pseudomyxoma peritonei with origin from mucinous 
tumour of ovary  is reported due to its rarity. 
Case Report  
A 40-years old woman with four live children was referred by a private practitioner 
with complaints of abdominal distension, dull aching abdominal pain and decreased 
appetite for three months. Her general and systemic examination was normal. 
Abdominal examination revealed ascites with cystic to firm mass of about 24 week 
gravid uterus size, well defined,  arising from pelvis, reaching up to umbilicus and with 
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restricted mobility. Same mass was felt through anterior and lateral fornices on vaginal 
examination. Ultrasonography of whole abdomen showed ascites with a large 18х 15 
cm hypoechoeic right adnexal mass with multiple internal septations and uterus, liver, 
gall bladder, spleen, kidney, urinary bladder and appendix appeared normal. CECT 
pelvis also showed a large well defined rounded hypodense mass lesion in pelvic region 
arising from right adnexa with CT attenuation value of 5-10 HU with fluid content and 
mild enhancing walls and normal left adnexa and uterus.  
 
Figure 1. Gross Appearance of Mucin Filled Right Ovarian Cyst 
 
Figure 2. Omentum Showing Pools of Mucin along with Metastatic Deposits from 
Adenocarcinoma of Ovary at 40x 
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Tumor marker CA-125 level was 96.7 U. patient was taken for staging laparotomy which 
revealed, around 1000cc mucinous ascites, dense adhesion of intestines with uterus, 
ovaries and omentum, tumor seedlings on gut, bladder, omentum, under surface of 
diaphragm, left ovary and uterus. There was a right sided multiloculated ovarian cyst 
filled with mucin of 18х15 cm size with smooth surface (Figure 1). Surgical debulking 
was done which included right sided salpingo-opherectomy and omentectomy with 
multiple biopsies. Removal of uterus, left side tube and ovary was not possible due to 
dense adhesions. 
Histopathological report showed a well differentiated adenocarcinoma ovary and 
metastatic deposits from mucin secreting adenocarcinoma in omentum (Figure 2). 
Pseudomyxma peritonei was designated as peritoneal mucinous carcinomatosis 
(PMCA). She was given cisplatin based chemotherapy after radiotherapy department 
consultation. Patient was discharged in good condition and was alright after six courses 
of chemotherapy. She did not consent for complete surgery after chemotherapy and 
continued to come for follow up till one year and there was no recurrence. 
Discussion 
Pseudomyxoma peritonei has an indolent course and presents with non specific 
symptoms. There occurs leakage of tumor cells in to peritoneal cavity from rupture of 
mucinous tumors of appendix or ovary. Peritoneal cavity is filled with septate jelly like 
fluid. Mucinous implants are found on all peritoneal surfaces and the omentum. This 
mucin causes compression of vessel, gastrointestinal tract and other abdominal 
structures and results in distortion and impaired function of these organs5. These cases 
present unexpectedly during laparotomy and laparoscopy. Some cases may present 
with intestinal obstruction associated with fibrosis caused by mucin. Its preoperative 
diagnosis is very difficult and tumor markers like CEA, CA125 CA19-9 have prognostic 
value. CECT is currently the optimal imaging modality for the diagnosis and staging of 
PMP and it predicts likelihood of complete cytoreduction6.  
 
Ultrasonography of abdomen may detect immobile ascites. Histology of the tumor 
shows clinical behavior of the tumor. PMP designated as DMPA is slow progressive and 
have prolonged survival whereas PMCA depicts metastatic adenocarcinoma with 
aggressive clinical course7. Standard treatment for pseudomyxoma peritonei is surgical 
debulking, in which the tumor is removed as much as possible. Intraperitoneal cisplatin 
chemotherapy is also a good modality of treatment for pseudomyxoma peritonei. 
Intraperitoneal hyperthermic chemotherapy is a newer modality of treatment for PMP 
and it is given for 30 minutes at 41-42celsius temperature using cisplatin (100 mg/m2) 
and mitomycin-c (25mg/m2) or 5-flurouracil and mitomycin5. Hyperthermia causes 
destruction of malignant cells and improves absorption of chemotherapy. Even with a 
better understanding and recent advances in the management of these cases, low 
incidence of PMP makes it difficult to study the disease and to evaluate the real 
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This condition can be encountered by any surgeon during the surgery and the best 
treatment is to perform complete cytoreduction after taking multiple biopsies and to do 
appendicectomy if possible. 
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